Frost & Sullivan’s Top 10 predictions for healthcare in 2021

January 16, 2021 Digital Health, Health Care, Innovation, Precision Medicine, Telehealth

From vaccines to virtual care, enterprise imaging to precision medicine, these are the growth areas that will shape the direction of healthcare, this year and beyond.

The year 2020 has been a year unlike any other year in our history. It has impacted the fabric of our society and life – but most importantly it has changed the healthcare industry forever.

The following 10 predictions that we have made for the global healthcare will define new ways of rethinking business and growth opportunities in 2021, and will help determine the future direction of the industry.

1. By the end of 2021, about 4 billion COVID-19 vaccine doses will be delivered globally.

These will be prioritized to immunize three target groups: the healthcare workforce, consisting of service providers, management & support workers in hospitals and social care; adults above 65; and about 45% of adults with comorbidities.

More than 50% of the expected production capacity of the vaccine candidates, which are in Phase III and are getting emergency approval, have been pre-booked by developed economies, such as the U.S., the E.U., Japan, Canada and the U.K.

Developing low- and middle-income countries are relying primarily on COVAX, the vaccines pillar of the Access to COVID-19 Tools Accelerator, which is co-led by the Coalition for Epidemic Preparedness Innovations, GAVI, the Vaccine Alliance and the World Health Organization. These organizations aim to deliver two billion doses by the end of 2021 equitably among all the 172 participating countries, which would result in around 25% of the global population getting vaccinated.

Pharmaceutical companies will be collaborating extensively for manufacturing, supply chain requirements, post-surveillance studies and storage. Digital enterprise vaccination management platforms will have to be built to inform the public, schedule vaccinations, automate mobile facilities, monitor outcomes and manage the supply chain for COVID-19 vaccines.

By Reenita Das | Healthcare IT News

Image Credit: Reenita Das / Healthcare IT News

READ MORE

About Peter Coffaro 510 Articles

Peter Coffaro is a growth-driven and strategic executive with over 25 years of progressive management success in the medical device industry. With a proven track record and recognized expertise, Peter has established himself as one of the top influencers in medical sales, as acknowledged by prestigious publications such as the World Journal of Orthopedics, Exponential Healthtech, and MedReps.com. Throughout his career, Peter has accumulated 10 years of combined sales management experience, excelling in various roles including Director, General Manager, Distributor, and Vice President. He has worked for industry-leading orthopedic companies such as Zimmer, DePuy, and Stryker, solidifying his deep knowledge and network within the field. Peter’s passion for innovation and emerging technologies led him to found OrthoFeed, an award-winning blog covering digital orthopedic news and emerging medical technologies. Through this platform, he stays at the forefront of the industry and contributes to the dissemination of valuable insights. Peter is a three-time Hall of Fame award winner at Johnson and Johnson, demonstrating his exceptional contributions and impact on the organization. His expertise extends to areas such as organizational development, business development, sales management, digital marketing, and professional education. Peter earned a B.S. degree in Biology and Chemistry from Northern Illinois University, further complementing his comprehensive understanding of the medical field. With his wealth of experience, strategic mindset, and dedication to advancing healthcare, Peter Coffaro is a valuable asset and leader in the medical device industry.